INGN Inogen Inc

8-K Current Report

Filed: February 24, 2026

Health Care

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Inogen Inc (INGN) 8-K current report filed with SEC EDGAR on February 24, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year 2025 results released Feb 24, 2026; details in Exhibit 99.1 press release
• INGN reported full fiscal year ended Dec 31, 2025 — key revenue, margins, and guidance figures in the exhibit

Item 7.01 · Regulation FD Disclosure

• Board approved $30M share repurchase program on Feb 20, 2026, expiring Dec 31, 2027
• Buybacks via open market at prevailing prices under Rule 10b-18, including 10b5-1 plans

+2 more insights

Get deeper insights on Inogen Inc

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.